Cargando…

Exploring the choices and outcomes of older patients with advanced kidney disease

A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004–2016) of a large single centre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyart, Rhodri, Aggett, Justine, Goodland, Annwen, Jones, Hayley, Prichard, Alison, Pugh, Julia, Thomas, Nerys, Roberts, Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286495/
https://www.ncbi.nlm.nih.gov/pubmed/32520955
http://dx.doi.org/10.1371/journal.pone.0234309
_version_ 1783544889109118976
author Pyart, Rhodri
Aggett, Justine
Goodland, Annwen
Jones, Hayley
Prichard, Alison
Pugh, Julia
Thomas, Nerys
Roberts, Gareth
author_facet Pyart, Rhodri
Aggett, Justine
Goodland, Annwen
Jones, Hayley
Prichard, Alison
Pugh, Julia
Thomas, Nerys
Roberts, Gareth
author_sort Pyart, Rhodri
collection PubMed
description A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004–2016) of a large single centre in the United Kingdom (1,216 patients), age, sex, comorbidity, poverty and frailty were used to predict choice of renal replacement therapy (RRT) over maximum conservative management (MCM). The impact of patient choice of RRT versus MCM was used to predict survival from the time of choice using multivariable Cox proportional hazards regression. Older age, female sex, greater poverty and greater frailty were associated with choosing MCM, whilst comorbidity had no significant impact on choice. At 5 years of follow up, 49% of all patients had died without receiving RRT. Over 70% of the patients choosing MCM died with better kidney function than the median level at which those starting RRT initiated treatment. Frailty and age were better predictors of survival than comorbidity and in patients with at least moderate frailty, RRT offered no survival benefit over MCM. In conclusion, analysing outcomes from the time of choice may improve shared decision making. Frailty should be routinely assessed and collected and further work may help predict which patients are unlikely to survive or progress to end stage renal disease and may not need to be burdened with making a pre-dialysis choice.
format Online
Article
Text
id pubmed-7286495
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72864952020-06-17 Exploring the choices and outcomes of older patients with advanced kidney disease Pyart, Rhodri Aggett, Justine Goodland, Annwen Jones, Hayley Prichard, Alison Pugh, Julia Thomas, Nerys Roberts, Gareth PLoS One Research Article A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004–2016) of a large single centre in the United Kingdom (1,216 patients), age, sex, comorbidity, poverty and frailty were used to predict choice of renal replacement therapy (RRT) over maximum conservative management (MCM). The impact of patient choice of RRT versus MCM was used to predict survival from the time of choice using multivariable Cox proportional hazards regression. Older age, female sex, greater poverty and greater frailty were associated with choosing MCM, whilst comorbidity had no significant impact on choice. At 5 years of follow up, 49% of all patients had died without receiving RRT. Over 70% of the patients choosing MCM died with better kidney function than the median level at which those starting RRT initiated treatment. Frailty and age were better predictors of survival than comorbidity and in patients with at least moderate frailty, RRT offered no survival benefit over MCM. In conclusion, analysing outcomes from the time of choice may improve shared decision making. Frailty should be routinely assessed and collected and further work may help predict which patients are unlikely to survive or progress to end stage renal disease and may not need to be burdened with making a pre-dialysis choice. Public Library of Science 2020-06-10 /pmc/articles/PMC7286495/ /pubmed/32520955 http://dx.doi.org/10.1371/journal.pone.0234309 Text en © 2020 Pyart et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pyart, Rhodri
Aggett, Justine
Goodland, Annwen
Jones, Hayley
Prichard, Alison
Pugh, Julia
Thomas, Nerys
Roberts, Gareth
Exploring the choices and outcomes of older patients with advanced kidney disease
title Exploring the choices and outcomes of older patients with advanced kidney disease
title_full Exploring the choices and outcomes of older patients with advanced kidney disease
title_fullStr Exploring the choices and outcomes of older patients with advanced kidney disease
title_full_unstemmed Exploring the choices and outcomes of older patients with advanced kidney disease
title_short Exploring the choices and outcomes of older patients with advanced kidney disease
title_sort exploring the choices and outcomes of older patients with advanced kidney disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286495/
https://www.ncbi.nlm.nih.gov/pubmed/32520955
http://dx.doi.org/10.1371/journal.pone.0234309
work_keys_str_mv AT pyartrhodri exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT aggettjustine exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT goodlandannwen exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT joneshayley exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT prichardalison exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT pughjulia exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT thomasnerys exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease
AT robertsgareth exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease